Share Prices & Company Research

Market News

02 Jan 2026 | 07:30

Suspension - Beximco Pharmaceuticals PLC



/**/

RNS Number : 3288N AIM 02 January 2026  

NOTICE   02/01/2026 7:30am   TEMPORARY SUSPENSION OF TRADING ON AIM   BEXIMCO PHARMACEUTICALS PLC   Trading on AIM for the under-mentioned securities has been temporarily suspended from 02/01/2026 7:30am, pending publication of the Company's annual audited accounts.   GLOBAL DEPOSITARY RECEIPTS (EACH REPRESENTING 1 ORDINARY SHARE OF BDT10 EACH), FULLY PAID (B0DM5S5) (US0885792061)   If you have any queries relating to the above, please contact the company's nominated adviser on +44 (0)20 3368 3551 / 3555.                          

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.  END  EXCFDMFFFEISEEE
Get in touch today
Join Redmayne Bentley
Talk to us now about opening a new portfolio or transferring your portfolio from another provider
0113 243 6941
Get in touch today
Contact your local office
Contact your local office to find out more
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.